Farmers National Bank Sells 123 Shares of The Clorox Company (NYSE:CLX)

Farmers National Bank reduced its stake in The Clorox Company (NYSE:CLX) by 2.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,160 shares of the company’s stock after selling 123 shares during the period. Farmers National Bank’s holdings in Clorox were worth $568,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of CLX. SG Americas Securities LLC increased its holdings in shares of Clorox by 1,525.7% in the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after purchasing an additional 61,576 shares during the last quarter. Mizuho Markets Americas LLC raised its holdings in shares of Clorox by 93.7% during the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after acquiring an additional 34,864 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its position in shares of Clorox by 15.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after acquiring an additional 18,687 shares during the last quarter. Advisors Asset Management Inc. grew its holdings in shares of Clorox by 257.5% in the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares in the last quarter. Finally, Game Plan Financial Advisors LLC bought a new stake in Clorox in the first quarter worth $1,025,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $165.32 on Wednesday. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The stock’s fifty day moving average is $153.17 and its two-hundred day moving average is $144.15. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The company has a market capitalization of $20.53 billion, a PE ratio of 85.66, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. As a group, analysts expect that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.51% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on CLX shares. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Wells Fargo & Company reduced their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Barclays raised their price objective on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. Finally, BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $146.13.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.